1 141 142 143
Number of results: 2851
Date Compound Product name Company Disease Action mechanism Type of Information
0000-00-00 Compound: bestttt asdasdasda asdasdasdas adsasdasdas Plant acquisition
0000-00-00 test test test test test Grant
0000-00-00 humanised IgG4 monoclonal antibody to the human toll-like receptor type 2 OPN-305 Opsona Therapeutics (Ireland) myelodysplastic syndromes monoclonal antibody. OPN-305 is a novel proprietary humanized IgG4 monoclonal antibody (MAb) against Toll-Like Receptor 2 (TLR2), a target within… Granting of the orphan status in the EU
0000-00-00 pppppppppp
0000-00-00 Compound: bestttt vkh vki Action_mechanism: Company acquisition
0000-00-00 Compound: bestttt Laboratory Indication Action_mechanism:
0000-00-00 knjnlnlnln Product name:lknk nl nl lnl Licensing agreement
0000-00-00 test Establishment of a new subsidiary in the EU
0000-00-00 assay service for understanding the impact of point mutations on protein therapeutic activity MutaMap™ ProImmune (UK) MutaMap is an in vitro assay system that explores the effect of deliberate point mutations on protein activity by substituting… Product launch
0000-00-00 SHP654 (BAX 888) • gene therapy. SHP654 (BAX 888) is an investigational factor VIII (FVIII) gene therapy intended to treat hemophilia A using a… Granting of the orphan status in the US